Control of insulin-like growth factor (IGF) action by regulation of IGF-I receptor expression

Endocrine Journal

Volumn 43, Issue SUPPL., 1996, Pages

  Roberts Jr , Charles T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Gene regulation; IGF I receptor; IGFs; Wilms tumor suppressor

Indexed keywords

CELL SURFACE RECEPTOR; INSULIN RECEPTOR; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; GENE EXPRESSION; GENE MUTATION; GROWTH REGULATION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; NEPHROBLASTOMA; PROSTATE HYPERTROPHY; RECEPTOR DENSITY; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; RECEPTOR, IGF TYPE 1; TRANSCRIPTION FACTORS; WILMS TUMOR; WT1 PROTEINS;

EID: 0030443672     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.suppl_s49     Document Type: Article

References (50)

1. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 10: 68-91.
2. Cohick WS, Clemmons DR (1993) The insulin-like growth factors. Annual Rev Physiol 55: 131-153.
3. Nissley SP, Lopaczynski W (1991) Insulin-like growth factor receptors. Growth Factors 5: 29-49.
4. LeRoith, D, Werner H, Beitner-Johnson D, Roberts Jr, CT (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16: 143-163.
5. Faria TN, Blakesley VA, Kato H, Stannard B, LeRoith D, Roberts Jr, CT (1994) Role of the carboxy-terminal domains of the insulin and insulin-like growth factor I receptors in receptor function. J Biol Chem 269: 1-7.
6. Rechler MM (1993) Insulin-like growth factor binding proteins. Vitam Horm 47: 1-114.
7. Baserga R, Sell C, Porcu P, Rubini M (1994) The role of the IGF-1 receptor in the growth and transformation of mammalian cells. Cell Prolif 27: 63-71.
8. Ikezu T, Okamoto T, Giambarella U, Yokota T, Nishimoto I (1995) In vivo coupling of insulin-like growth factor II/mannose-6-phosphate receptor to heteromeric G proteins. J Bio Chem 270: 29224-29228.
9. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (IgF-1) and type 1 IGF receptor (Igflr). Cell 75: 59-72.
10. Baker J, Liu JP, Robertson EJ, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
11. Werner H, Woloschak M, Adamo M, Shen-Orr Z, Roberts Jr, CT, LeRoith D (1989) Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 86: 7451-7455.
12. Alexandrides T, Moses AC, Smith RJ (1989) Developmental expression of receptors for insulin, insulin-like growth factor I (IGF-I), and IGF-II in rat skeletal muscle. Endocrinology 124: 1064-1076.
13. Myers Jr, JG, Su X-J, Cheatham B, Jachna BR, Glasheen EM, Backer JM, White MF (1993) IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132: 1421-1430.
14. Myers Jr, MG, White MF (1993) The new elements of insulin signaling: Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42: 643-650.
15. Sasaoka T, Rose DW, Juhn BH, Saltiel AR, Draznin B, Olefsky JM (1994) Evidence for a functional role of She proteins in mitogenic signaling indued by insulin, insulin-like growth factor-I, and epidermal growth factor. J Biol Chem 269: 13689-13694.
16. Boguski MS, McCormick F (1993) Proteins regulating Ras and its relatives. Nature 366: 643-653.
17. Condorelli G, Smith RJ (1993) Two alternatively spliced forms of the IGF-I receptor have distinct biological activities and hormone-induced internalization rates. Exp Clin Endocrinol 101: 95-97.
18. Condorelli G, Bueno R, Smith R (1994) Two alternatively spliced forms of the human insulin-like growth factor I receptor have distinct biological activities and internalization kinetics. J Biol Chem 269: 8510-8516.
19. Werner H, Shen-Orr Z, Stannard B, Burguera B, Roberts Jr, CT, LeRoith D (1990) Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in the idney. Diabetes 39: 1490-1497.
20. Papa V, Hartmann KKP, Rosenthal S, Maddux BA, Siiteri PK, Goldfine ID (1991) Progestins induce down-regulation of insulin-like growth factor (IGF-I) receptors in human breast cancer cells; potential autocrine role of IGF-II. Mol Endocrinol 5: 709-717.
21. Rosenthal SM, Brown EJ, Brunetti A, Goldfine ID (1991) Fibroblast growth factor inhibits insulin-like growth factor II (IGF-II) gene expression and increases IGF-I receptor abundance in BC3H-1 muscle cells. Mol Endocrinol 5: 678-684.
22. Goldfine ID, Papa V, Vigneri R, Siiteri P, Rosenthal SM (1992) Progestin regulation of insulin and insulin-like growth factor I receptors in cultured human breast cancer cells. Mol Endocrinol 6: 1665-1672.
23. Mulroney SE, Haramati A, Werner H, Bondy C, Roberts Jr, CT, LeRoith D (1992) Altered expression of insulin-like growth factor-I (IGF-I) and IGF-I receptor genes after unilateral nephrectomy in immature rats. Endocrinolgy 130: 249-256.
24. Yamamto H, Prager D, Yamasaki H, Melmed S (1993) Rat pituitary GC cell insulin-like growth factor I receptor regulation. Endocrinology 133: 1420-1425.
25. Eshet R, Werner H, Klinger B, Silbergeld A, Laron Z, LeRoith D, Roberts Jr, CT (1993) Up-regulation of insulin-like growth factor-I (IGF-I) receptor gene expression in patients with reduced serum IGF-I levels. J Mol Endocrinol 10: 115-120.
26. Rubini M, Werner H, Gandini E, Roberts Jr, CT, LeRoith D, Baserga R (1994) Platelet-derived growth factor increases the activity of the promoter of the IGF-I receptor gene. Exp Cell Res 211: 374-379.
27. Neuenschwander S, Roberts Jr, CT, LeRoith D (1995) Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 136: 4298-4303.
28. Shapiro DN, Jones BG, Shapiro LH, Dias P, Houghton PJ (1994) Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J Clin Invest 94: 1235-1242.
29. Resnicoff M, Sell C, Rubini M, Coppola D, Ambrose D, Baserga R, Rubin R (1994) Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor-I (IGF-I) receptor are nontumorigenic and induce regression of wild-type tumors. Cancer Res 54: 2218-2222.
30. Werner H, Stannard B, Bach MA, LeRoith D, Roberts Jr, CT (1990) Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem Biophys Res Commun 169: 1021-1027.
31. Werner H, Bach MA, Stannard B, Roberts Jr, CT, LeRoith D (1992) Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol Endocrinol 6: 1545-1558.
32. Van Heyningen V, Hastie ND (1992) Wilms' tumor: Reconciling genetics and biology. Trends Genet 8: 16-21.
33. Rose EA, Glaser T, Jones C, Smith CL, Lewis WH, Call KM, Minden M, Champagne E, Bonetta L, Yeger H, Housman DE (1990) Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell 60: 494-508.
34. Gessler M, Poustka A, Cavence W, Neve RL, Orkin SH, Bruns GAP (1990) Homozygous deletion in Wilms' tumors of a zinc finger geneidentified by chromosome jumping. Nature 343: 774-778.
35. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
36. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher III, FJ (1991) Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6: 2339-2348.
37. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1990) Isolation, characterization and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11: 1707-1712.
38. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D (1991) Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes and Dev 5: 1345-1356.
39. Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND (1992) Zinc finger point mutations within the WT1 gene in Wilms' tumor patients. Proc Natl Acad Sci USA 89: 4791-4795.
40. Madden SL, Cook DM, Morris JF, Gashler A, Sukahatme VP, Rauscher III, FJ (1991) Transcriptional repression mediated by the WT1 Wilms' tumor gene product. Science 253: 1550-1553.
41. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher III, FJ (1992) Repression of the insulin-like growth factor II gene by the Wilms' tumor suppressor WT1. Science 257: 674-678.
42. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher III FJ, Sens DA Garvin AJ, LeRoith D, Roberts Jr, CT (1993) Increased expression of the insulin-like growth factor I receptor gene, IGFIR, in Wilms' tumor is correlated with modulation of IGFIR promoter by the WT1 Wilms' tumor gene product. Proc Natl Acad Sci USA 90: 5828-5832.
43. Werner H, Rauscher III FJ, Sukhatme VP, Drummond IA, Roberts Jr, CT, LeRoith D (1994) Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269: 12577-12582.
44. Werner H, Shen-Orr Z, Rauscher III FJ, Morris JF, Roberts Jr, CT, LeRoith D (1995) Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol 15: 3516-3522.
45. Roberts Jr, CT (1995) Insulin-like growth factors and Wilms tumor. In: LeRoith D (ed) Moderator. Insulin-like growth factors and cancer. Ann Intern Med 122: 54-59.
46. Ren-Qui Q, Schmitt S, Ruelicke T, Stallmach T, Schoenle EJ (1996) Autocrine regulation of growth by insulin-like growth factor (IGF)-II mediated by type I IGF receptor in Wilms tumor cells. Pediatric Research 39: 160-165.
47. Gansler T, Furlanetto R, Gramling TS, Robinson KA, Blocker N, Buse MG, Sens DA, Garvin AJ (1989) Antibody to type I insulin-like growth factor receptor inhibits growth of Wilm's tumor in culture and in athymic mice. Am J Pathol 135: 961-966.
48. McNeal JE (1990) Pathology of benign prostatic hyperplasia: Insight into etiology. Urol Clin N Amer 17: 477-486.
49. Peehl DM, Cohen P, Rosenfeld RG (1995) The insulin-like growth factor system in the prostate. World J Urol 13: 306-311.
50. Dong D, Rajah R, Roberts Jr, CT, Rosenfeld RG, Peehl DM, Cohen P (1996) Decreased expression of the Wilms tumor gene WT1 in the prostatic stroma of patients with benign prostatic hyperplasia resulting in increased IGF-II and IGF-IR gene expression. 10 th International Congress of Endocrinology, San Francisco, CA, Abstract P1-518.